Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1591 of 5804
-
Zapping away tremors: scientists probe how electrical stimulation calms shaky hands
Knowledge-focused TerminatedThe purpose of this study is to understand the neurophysiological mechanisms of peripheral electrical stimulation (PES) in modulating supraspinal tremorogenic input to motoneurons. For this purpose, the investigators will use transcutaneous PES, high-density electromyography (HD-…
Phase: NA • Sponsor: Shirley Ryan AbilityLab • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Blood transfusions after ICU: a new hope for tired survivors?
Symptom relief OngoingOn discharge from intensive care (ICU) patients are often severely anaemic (have a low level of haemoglobin (Hb) in their red blood cells (RBC)). Anaemia can persist for many months making patients feel tired and fatigued. Regaining pre-illness health and energy levels can take a…
Phase: NA • Sponsor: University of Edinburgh • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Could an antioxidant help treat chronic fatigue? new trial tests NAC
Disease control OngoingChronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS) is an unexplained multisymptom/multisystem disorder for which there are currently no validated treatments. The present exploratory clinical trial aims to advance our understand of the mechanisms of in situ GSH synthesis …
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New vaccine aims to fight breast cancer by training the immune system
⭐️ VACCINE ⭐️ OngoingThis is a phase I study looking at the safety of cancer peptides combined with adjuvant and GM-CSF in subjects with estrogen receptor (ESR) positive breast cancer. The primary objective of the study is to determine the safety of of the peptide vaccine. The secondary objective is …
Phase: PHASE1 • Sponsor: Herbert Lyerly • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:08 UTC
-
Laser light could heal tough wounds in seniors at home
Symptom relief OngoingThe aim of this quasi-experimental prospective study is to evaluate the effectiveness of photobiomodulation treatment on hard-to-heal ulcers of various diagnosed aetiologies in frail older adults, admitted to municipal home healthcare. The study also include evaluation of cost-ef…
Phase: NA • Sponsor: Umeå University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
AI listens in on 911 calls to catch strokes before It's too late
Knowledge-focused OngoingMore than 12.000 patients suffer acute stroke in Norway every year, but less than half of them reach hospital within the current treatment window for thrombolysis. Stroke is the third-highest cause of death and the number one cause of severe disability requiring long time care at…
Sponsor: Haukeland University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New pill aims to plug kidney leaks in rare disease
Disease control Recruiting nowThis study is an exploratory, randomized, double-blind, multicenter, placebo-controlled study with repeated doses of AP1189. The study population will consist of patients with idiopathic membranous nephropathy (iMN) and severe proteinuria who are on ACE inhibitor or angiotensin I…
Phase: PHASE2 • Sponsor: SynAct Pharma Aps • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can ocrelizumab tame MS inflammation from the start? new study aims to find out
Disease control OngoingNewly diagnosed relapsing multiple sclerosis (MS) and high risk clinically isolated syndrome (CIS) patients will be treated with ocrelizumab at disease onset to see if treatment favorably alters CSF markers of chronic inflammation.
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:15 UTC
-
Precision radiation may spare brain function in lung cancer patients
Disease control OngoingThis phase II trial investigates how stereotactic radiosurgery affects brain functions while treating patients with small cell lung cancer that has spread to the brain (brain metastasis). Standard of care treatment consists of whole brain radiation therapy, which targets the enti…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a single X-Ray tame COVID-19 lung inflammation?
Disease control OngoingLow doses of radiation in the form of chest x-rays has been in the past to treat people with pneumonia. This treatment was thought to reduce inflammation and was found to be effective without side effects. However, it was an expensive treatment and was eventually replaced with le…
Phase: PHASE2 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo therapy targets tough cancers
Disease control Recruiting nowBOLD-100 is an intravenously administered sterile solution containing the ruthenium-based small molecule. BOLD-100 has been shown to preferentially decrease the expression of GRP78 in tumour cells and ER stressed cells when compared to normal cells. BOLD-100 will be combined with…
Phase: PHASE1, PHASE2 • Sponsor: Bold Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can estrogen patches strengthen bones in anorexia?
Disease control Recruiting nowRandomized, placebo-controlled study investigating the use of physiologic, transdermal estrogen for low bone mass in adult women with anorexia nervosa.
Phase: PHASE2 • Sponsor: Pouneh K. Fazeli, MD • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New clip device shows promise for leaky heart valve in Real-World study
Disease control OngoingThe bRIGHT EU PAS study is an observational real-world study evaluating severe tricuspid regurgitation patients treated with the Abbott TriClip™ device (bRIGHT EU Post-Approval Study).
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a simple sugar protect bone marrow transplant patients?
Disease control CompletedHigh dose chemotherapy and radiation used as preparative regimens in patients undergoing an allogeneic hematopoietic stem cell transplant (HSCT) disrupts intestinal homeostasis by damaging the intestinal epithelium and altering the intestinal microbiome. The investigators hypothe…
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Which chemo combo works best for older pancreatic cancer patients?
Disease control OngoingThis phase II trial compares two treatment combinations: gemcitabine hydrochloride and nab-paclitaxel, or fluorouracil, leucovorin calcium, and liposomal irinotecan in older patients with pancreatic cancer that has spread to other places in the body (metastatic). Drugs used in ch…
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can ritalin Jump-Start the brain after a coma?
Disease control OngoingPhase 1 of the STIMPACT trial is an open label,dose-escalation,safety study of intravenous (IV) methylphenidate (MPH) therapy in patients with disorders of consciousness (DoC) caused by severe brain injuries.
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Breath and blood tests could spot lung cancer early
Diagnosis OngoingDECAMP 1 PLUS aims to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules (8-25 mm). Molecular biomarkers for lung cancer diagnosis measured in minimally invasive and non-invasive biospecimens may be able to distinguish between mal…
Sponsor: Boston University • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
New drug cocktail shows promise for Tough-to-Treat lymphomas
Disease control OngoingThis phase II trial studies how well polatuzumab vedotin and combination chemotherapy work in treating patients with previously untreated double, triple hit lymphoma, Double Expressor Lymphoma or High-Grade B Cell Lymphoma. Polatuzumab vedotin is a monoclonal antibody that works …
Phase: PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a simple test guide chemo for pancreatic cancer patients?
Knowledge-focused OngoingTo date, there have been no Canadian led neoadjuvant or peri-operative trials, this multicentre design gives the opportunity to build more experience with this strategy across Canada in more institutions. The design of this prospective trial will also test our important hypothese…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Video games prescribed: new study tests exergaming to ease cancer fatigue
Symptom relief Recruiting nowThis overall objective of the RCT is to test an intervention to overcome the PA barriers for head and neck cancer (HNC) patients during the first 6 months after their treatment. PAfitME stands for a personalized Physical Activity intervention with fitness graded Motion Exergames.…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC